Reality and Truth: Balancing the Hope and the Hype of Real-World Evidence

Affiliations

¹ From The George Institute for Global Health, University of New South Wales, Sydney, Australia. apatel@georgeinstitute.org.
² From The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Editorial

Anushka Patel et al. Circulation. 2017.

. 2017 Jul 18;136(3):260-262.

doi: 10.1161/CIRCULATIONAHA.117.029233.

¹ From The George Institute for Global Health, University of New South Wales, Sydney, Australia. apatel@georgeinstitute.org.
² From The George Institute for Global Health, University of New South Wales, Sydney, Australia.

No abstract available

Keywords: Editorials; SGLT proteins; causality; clinical trial; diabetes mellitus; observational study.

Comment on

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group*. Kosiborod M, et al. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. Epub 2017 May 18. Circulation. 2017. PMID: 28522450 Free PMC article. Clinical Trial.